The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Likelihood-enhanced fast translation functions
McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., & Read, R. J. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905001617 · Cited by 1,639
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Self-citationDeisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc
Idusogie, E. E., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Wong, P. Y., Ultsch, M., Meng, Y. G., & Mulkerrin, M. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4178 · Cited by 424
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Martin, W. L., West, A. P., Gan, L., & Bjorkman, P. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00230-1 · Cited by 391
Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlén, M., & Jones, T. A. (1995) · Structure · doi:10.1016/s0969-2126(01)00157-5 · Cited by 372
The Uppsala Electron-Density Server
Kleywegt, G. J., Harris, M. R., Zou, J.-Y., Taylor, T. C., Wählby, A., & Jones, T. A. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904013253 · Cited by 359
The Structure of a Human Type III Fcγ Receptor in Complex with Fc
Radaev, S., Motyka, S., Fridman, W.-H., Sautes-Fridman, C., & Sun, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100350200 · Cited by 354
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354
Okazaki, A., Shoji-Hosaka, E., Nakamura, K., Wakitani, M., Uchida, K., Kakita, S., Tsumoto, K., Kumagai, I., & Shitara, K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.007 · Cited by 337
Self-citationJefferis, R., Lund, J., & Pound, J. D. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01188.x · Cited by 329
Davies, J., Jiang, L., Pan, L., LaBarre, M. J., Anderson, D., & Reff, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1119 · Cited by 327
Niwa, R., Shoji-Hosaka, E., Sakurada, M., Shinkawa, T., Uchida, K., Nakamura, K., Matsushima, K., Ueda, R., Hanai, N., & Shitara, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2068 · Cited by 325
Self-citationAge-related galactosylation of the N-linked oligosaccharides of human serum IgG.
Parekh, R., Roitt, I., Isenberg, D., Dwek, R., & Rademacher, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1731 · Cited by 302
Human Antibody Effector Function
Burton, D. R., & Woof, J. M. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60486-1 · Cited by 265
Agalactosyl glycoforms of IgG autoantibodies are pathogenic
Rademacher, T. W., Williams, P., & Dwek, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6123 · Cited by 253
Niwa, R., Natsume, A., Uehara, A., Wakitani, M., Iida, S., Uchida, K., Satoh, M., & Shitara, K. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.08.009 · Cited by 244
Self-citationRole of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding
Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S. P., Goodall, M., & Jefferis, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107478200 · Cited by 236
Recent changes to RasMol, recombining the variants
Bernstein, H. J. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01606-6 · Cited by 230
Niwa, R., Hatanaka, S., Shoji-Hosaka, E., Sakurada, M., Kobayashi, Y., Uehara, A., Yokoi, H., Nakamura, K., & Shitara, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0850 · Cited by 227
Self-citationCorper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., & Sutton, B. J. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-374 · Cited by 224
Effect of gamma rays at the dihydrofolate reductase locus: Deletions and inversions
Urlaub, G., Mitchell, P. J., Kas, E., Chasin, L. A., Funanage, V. L., Myoda, T. T., & Hamlin, J. (1986) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01671941 · Cited by 222
Yamaguchi, Y., Nishimura, M., Nagano, M., Yagi, H., Sasakawa, H., Uchida, K., Shitara, K., & Kato, K. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.10.002 · Cited by 204
Self-citationNiwa, R., Sakurada, M., Kobayashi, Y., Uehara, A., Matsushima, K., Ueda, R., Nakamura, K., & Shitara, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2263 · Cited by 187
Self-citationTakahashi, N., Ishii, I., Ishihara, H., Mori, M., Tejima, S., Jefferis, R., Endo, S., & Arata, Y. (1987) · Biochemistry · doi:10.1021/bi00378a023 · Cited by 163
Papac, D. I. (1998) · Glycobiology · doi:10.1093/glycob/8.5.445 · Cited by 151
Sprague, E. R., Wang, C., Baker, D. A., & Björkman, P. J. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040148 · Cited by 137
YOUINGS, A., Chang, S.-C., Dwek, R. A., & Scragg, I. G. (1996) · Biochemical Journal · doi:10.1042/bj3140621 · Cited by 136
Recognition of immunoglobulins by Fcγ receptors
Radaev, S., & Sun, P. D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00036-6 · Cited by 136
Lund, J., Tanaka, T., Noriko, T., Sármay, G., Arata, Y., & Jefferis, R. (1990) · Molecular Immunology · doi:10.1016/0161-5890(90)90103-7 · Cited by 129
Deisenhofer, J., Colman, P. M., Epp, O., & Huber, R. (1976) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1976.357.2.1421 · Cited by 123
Kumpel, B. M., Rademacher, T. W., Rook, G. A. W., Williams, P., & Wilson, I. (1994) · PubMed · Cited by 105
Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
Edberg, J., & Kimberly, R. (1997) · Journal of Immunology · doi:10.4049/jimmunol.159.8.3849 · Cited by 103
Yamaguchi, Y., Kim, H., Kato, K., Masuda, K., Shimada, I., & Arata, Y. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00010-8 · Cited by 80
Self-citationStructural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp- lpr/lpr mice.
Mizuochi, T., Hamako, J., Nose, M., & Titani, K. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1794 · Cited by 73
The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.
Kumpel, B. M., Wang, Y., Griffiths, H. L., Hadley, A. G., & Rook, G. A. W. (1995) · PubMed · Cited by 71
Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas
Rothman, R. J., Warren, L., Vliegenthart, J. F. G., & Hård, K. (1989) · Biochemistry · doi:10.1021/bi00429a065 · Cited by 70
The biological activity of human monoclonal IgG anti-D is reduced by β-galactosidase treatment
Kumpel, B. M., Wang, Y., Griffiths, H. L., Hadley, A. G., & Rook, G. A. W. (1995) · Human Antibodies · doi:10.3233/hab-1995-6301 · Cited by 68
Natsume, A., Wakitani, M., Yamane‐Ohnuki, N., Shoji-Hosaka, E., Niwa, R., Uchida, K., Satoh, M., & Shitara, K. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.07.025 · Cited by 67
Self-citationLund, J., Takahashi, N., Nakagawa, H., Goodall, M. D., Bentley, T., Hindley, S., Tyler, R., & Jefferis, R. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90145-2 · Cited by 62
Nakao, H., Nishikawa, A., Nishiura, T., Kanayama, Y., Tarui, S., & Taniguchi, N. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90142-y · Cited by 36
The Current Stream and Prospect of Glycoscience Application-Therapeutic Antibodies-
Satoh, M., Shitara, K., & Hanai, N. (2006) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.18.129 · Cited by 12
Self-citation
Research works printed but not linked: 5
- Mizuochi, 1987, Structures of the sugar chains of mouse immunoglobulin G, Arch. Biochem. Biophys., 257, 387, 10.1016/0003-9861(87)90581-9 · doi:10.1016/0003-9861(87)90581-9
- Lund, 1993, Glycosylation of human IgG subclass and mouse IgG2b heavy chains secreted by mouse J558L transfectoma cell lines as chimeric antibodies, Hum. Antibodies Hybridomas, 4, 20, 10.3233/HAB-1993-4104 · doi:10.3233/hab-1993-4104
- Yabe, 1986, Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium, In Vitro Cell Dev. Biol., 22, 363, 10.1007/BF02623523 · doi:10.1007/bf02623523
- Kato, 1991, Complete assignment of the methionyl carbonyl carbon resonances in switch variant anti-dansyl antibodies labeled with [1-13C]methionine, Biochemistry, 30, 270, 10.1021/bi00215a037 · doi:10.1021/bi00215a037
- Yamaguchi, 2006, Structural glycobiology by stable-isotope-assisted NMR spectroscopy, Vol. 2, 219
Cited by
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
“These studies map the binding site for all four of these ligands to the hinge-proximal and lower hinge region of the CH2 domai”
BackgroundFerrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
Smith, K. G. C., & Clatworthy, M. R. (2010) · Nature Reviews Immunology · doi:10.1038/nri2762 · Cited by 543
Metadata
- Authors
- Matsumiya, S., Yamaguchi, Y., Saito, J.-I., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., & Kato, K.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 368
- Issue
- 3
- Pages
- 767-779
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W1989407795
- Cited by
- 278
- References
- 55
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency (17046017)
- Japan Health Sciences Foundation
- Core Research for Evolutional Science and Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.